|
|
See Header: Neoplasm of unsp behavior of other genitourinary organs
ICD-10 (CM) Code and Descriptor
|
D49.59 |
Neoplasm of unspecified behavior of other genitourinary organ
|
D4959 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 40.45%
|
22.97%
|
13.65%
|
7.91%
|
4.49%
|
2.97%
|
2.34%
|
1.59%
|
1.07%
|
0.64%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D49.59*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
1,115
|
1,119
|
|
84153
|
ASSAY OF PSA TOTAL |
701
|
701
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
551
|
552
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
460
|
460
|
|
80053
|
COMPREHEN METABOLIC PANEL |
416
|
416
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
406
|
36,245
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
261
|
261
|
|
82565
|
ASSAY OF CREATININE |
250
|
250
|
|
80048
|
METABOLIC PANEL TOTAL CA |
212
|
212
|
|
J2405
|
ONDANSETRON HCL INJECTION |
212
|
914
|
|
J3010
|
FENTANYL CITRATE INJECTION |
207
|
315
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
197
|
268
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
187
|
4,646
|
|
86304
|
IMMUNOASSAY TUMOR CA 125 |
182
|
182
|
|
G1004
|
CDSM NDSC |
180
|
284
|
|
78306
|
BONE IMAGING WHOLE BODY |
156
|
156
|
|
71260
|
CT THORAX DX C+ |
150
|
150
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
146
|
735
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
134
|
540
|
|
A9503
|
TC99M MEDRONATE |
133
|
133
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D49.59 related to the following DRG Codes:
656-658
686-688
|
